NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States

Search Results

2921. Pediatric information for x-ray imaging device premarket notifications: guidance for industry and Food and Drug Administration staff

2922. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry

2923. FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff

2924. Technical considerations for additive manufactured medical devices: guidance for industry and Food and Drug Administration staff

2925. Use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in blood and blood components

2926. Software as a medical device (SAMD): clinical evaluation : guidance for industry and Food and Drug Administration staff

2928. Systemic antibacterial and antifungal drugs: susceptibility test interpretive criteria labeling for NDAs and ANDAs

2929. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system

2930. Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice